English

CHINA BIOPHARMACEUTICALS HOLDINGS INC

EDGAR

Quarterly report (10-Q) · filed 2009-10-29

64 filing records in this dataset, filed from 1995-10-13 to 2009-10-29. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

17.1 million USD

2009-09-30 · USD

Exact inputs and evidence

Revenue: 17051816 USD Source

Operating margin

26.47%

2009-09-30 · %

Exact inputs and evidence

Operating Income: 4513743 USD Source
Revenue: 17051816 USD Source

Cash and cash equivalents: 2.85 million USD 2009-09-30 Source
Exact value

2847192 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-10-29.

Financial data available through: 2005-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2005-12-31
Operating income: 3 of 11 periods available· newest 2005-12-31
Net income: 11 of 11 periods available· newest 2005-12-31
Operating cash flow: 8 of 11 periods available· newest 2003-02-28
capital expenditure: No compatible figures in this window
Total assets: 9 of 11 periods available· newest 2005-12-31
Total liabilities: 8 of 11 periods available· newest 2005-12-31
Current assets: 2 of 11 periods available· newest 2005-12-31
Current liabilities: 2 of 11 periods available· newest 2005-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2005-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+798.7%

Prior period

USD 3.44 million

2004-01-01 – 2004-12-31
Current period

USD 30.95 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

30948568 − 3443545 = 27505023 USD

3443545 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
30948568 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2005-12-31 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Year-over-year change in Revenue: 27505023 USD Concept: fundies:Revenue Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 30948568 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001144204-06-035948.txt#10254 Input fundies:Revenue: 3443545 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001144204-06-035948.txt#10254
The citation records this snapshot. The page link may show a newer release later.
Net income
+174%

Prior period

USD 350,640

2004-01-01 – 2004-12-31
Current period

USD 960,685

2005-01-01 – 2005-12-31

Exact inputs and evidence

960685 − 350640 = 610045 USD

350640 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
960685 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2005-12-31 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Year-over-year change in Net income: 610045 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 960685 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001144204-06-035948.txt#10945 Input fundies:NetIncome: 350640 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001144204-06-035948.txt#10945
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2005 2005-01-01 – 2005-12-31

Revenue USD 30.95 million 100% of revenue
Cost of revenue USD 24.76 million 80% of revenue
Operating expenses USD 3.46 million 11% of revenue
Operating income USD 2.73 million 8.8% of revenue
Tax, interest and other Derived USD 1.77 million 5.7% of revenue
Net income USD 960,685 3.1% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.
1999 Not shown: operating income or net income is not reported.
2000 Not shown: operating income or net income is not reported.
2001 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.
2003 Not shown: operating income or net income is not reported.
2003 48%17%36%
2004 10%86%
2005 91%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1997 1996-03-01 – 1997-02-28	911000	Unavailable	Unavailable	Unavailable	647000	Unavailable	Source 1996-03-01 – 1997-02-28: 911000 USD Inspect Revenue Open source 1996-03-01 – 1997-02-28: 647000 USD Inspect Net Income Open source 1996-03-01 – 1997-02-28: -37000 USD Inspect Operating Cash Flow Open source
1998 1997-03-01 – 1998-02-28	-270000	Unavailable	Unavailable	Unavailable	-518000	Unavailable	Source 1997-03-01 – 1998-02-28: -270000 USD Inspect Revenue Open source 1997-03-01 – 1998-02-28: -518000 USD Inspect Net Income Open source 1997-03-01 – 1998-02-28: -43000 USD Inspect Operating Cash Flow Open source
1999 1998-03-01 – 1999-02-28	-578000	Unavailable	Unavailable	Unavailable	-814000	Unavailable	Source 1998-03-01 – 1999-02-28: -578000 USD Inspect Revenue Open source 1998-03-01 – 1999-02-28: -814000 USD Inspect Net Income Open source 1998-03-01 – 1999-02-28: -236000 USD Inspect Operating Cash Flow Open source
2000 1999-03-01 – 2000-02-29	403000	Unavailable	Unavailable	Unavailable	46000	Unavailable	Source 1999-03-01 – 2000-02-29: 403000 USD Inspect Revenue Open source 1999-03-01 – 2000-02-29: 46000 USD Inspect Net Income Open source 1999-03-01 – 2000-02-29: -104000 USD Inspect Operating Cash Flow Open source
2001 2000-03-01 – 2001-02-28	-383000	Unavailable	Unavailable	Unavailable	-703000	Unavailable	Source 2000-03-01 – 2001-02-28: -383000 USD Inspect Revenue Open source 2000-03-01 – 2001-02-28: -703000 USD Inspect Net Income Open source 2000-03-01 – 2001-02-28: -168000 USD Inspect Operating Cash Flow Open source
2002 2001-03-01 – 2002-02-28	477000	Unavailable	Unavailable	Unavailable	104000	Unavailable	Source 2001-03-01 – 2002-02-28: 477000 USD Inspect Revenue Open source 2001-03-01 – 2002-02-28: 104000 USD Inspect Net Income Open source 2001-03-01 – 2002-02-28: -178000 USD Inspect Operating Cash Flow Open source
2003 2002-03-01 – 2003-02-28	-396000	Unavailable	Unavailable	Unavailable	-749000	Unavailable	Source 2002-03-01 – 2003-02-28: -396000 USD Inspect Revenue Open source 2002-03-01 – 2003-02-28: -749000 USD Inspect Net Income Open source 2002-03-01 – 2003-02-28: -190000 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	1016733	362021 Derived	654712	170537 Derived	484175	Unavailable	Source 2003-01-01 – 2003-12-31: 1016733 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 654712 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: 484175 USD Inspect Net Income Open source
2004 2004-01-01 – 2004-12-31	3443545	2977362 Derived	466183	115543 Derived	350640	Unavailable	Source 2004-01-01 – 2004-12-31: 3443545 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: 466183 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: 350640 USD Inspect Net Income Open source
2005 2005-01-01 – 2005-12-31	30948568	28215894 Derived	2732674	1771989 Derived	960685	Unavailable	Source 2005-01-01 – 2005-12-31: 30948568 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 2732674 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 960685 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 30.9M 2005

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-02-28	Revenue	911000	Revenue: 911000 Open source
19981998-02-28	Revenue	-270000	Revenue: -270000 Open source
19991999-02-28	Revenue	-578000	Revenue: -578000 Open source
20002000-02-29	Revenue	403000	Revenue: 403000 Open source
20012001-02-28	Revenue	-383000	Revenue: -383000 Open source
20022002-02-28	Revenue	477000	Revenue: 477000 Open source
20032003-02-28	Revenue	-396000	Revenue: -396000 Open source
20032003-12-31	Revenue	1016733	Revenue: 1016733 Open source
20042004-12-31	Revenue	3443545	Revenue: 3443545 Open source
20052005-12-31	Revenue	30948568	Revenue: 30948568 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

798.7% 2005

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19971997-02-28	Year over year	-34%	Revenue: 911000 Open source Revenue: 1380000 Open source
19981998-02-28	Year over year	-129.6%	Revenue: -270000 Open source Revenue: 911000 Open source
19991999-02-28	Year over year	114.1%	Revenue: -578000 Open source Revenue: -270000 Open source
20002000-02-29	Year over year	-169.7%	Revenue: 403000 Open source Revenue: -578000 Open source
20012001-02-28	Year over year	-195%	Revenue: -383000 Open source Revenue: 403000 Open source
20022002-02-28	Year over year	-224.5%	Revenue: 477000 Open source Revenue: -383000 Open source
20032003-02-28	Year over year	-183%	Revenue: -396000 Open source Revenue: 477000 Open source
20032003-12-31	Year over year	No prior comparable period	Revenue: 1016733 Open source
20042004-12-31	Year over year	238.7%	Revenue: 3443545 Open source Revenue: 1016733 Open source
20052005-12-31	Year over year	798.7%	Revenue: 30948568 Open source Revenue: 3443545 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 8.8% 2005

Net margin 3.1% 2005

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1997-02-28	Operating margin	Not reported	Revenue: 911000 Open source
1998-02-28	Operating margin	Not reported	Revenue: -270000 Open source
1999-02-28	Operating margin	Not reported	Revenue: -578000 Open source
2000-02-29	Operating margin	Not reported	Revenue: 403000 Open source
2001-02-28	Operating margin	Not reported	Revenue: -383000 Open source
2002-02-28	Operating margin	Not reported	Revenue: 477000 Open source
2003-02-28	Operating margin	Not reported	Revenue: -396000 Open source
20032003-12-31	Operating margin	64.4%	Operating Income: 654712 Open source Revenue: 1016733 Open source
20042004-12-31	Operating margin	13.5%	Operating Income: 466183 Open source Revenue: 3443545 Open source
20052005-12-31	Operating margin	8.8%	Operating Income: 2732674 Open source Revenue: 30948568 Open source
19971997-02-28	Net margin	71%	Net Income: 647000 Open source Revenue: 911000 Open source
19981998-02-28	Net margin	191.9%	Net Income: -518000 Open source Revenue: -270000 Open source
19991999-02-28	Net margin	140.8%	Net Income: -814000 Open source Revenue: -578000 Open source
20002000-02-29	Net margin	11.4%	Net Income: 46000 Open source Revenue: 403000 Open source
20012001-02-28	Net margin	183.6%	Net Income: -703000 Open source Revenue: -383000 Open source
20022002-02-28	Net margin	21.8%	Net Income: 104000 Open source Revenue: 477000 Open source
20032003-02-28	Net margin	189.1%	Net Income: -749000 Open source Revenue: -396000 Open source
20032003-12-31	Net margin	47.6%	Net Income: 484175 Open source Revenue: 1016733 Open source
20042004-12-31	Net margin	10.2%	Net Income: 350640 Open source Revenue: 3443545 Open source
20052005-12-31	Net margin	3.1%	Net Income: 960685 Open source Revenue: 30948568 Open source
19971997-02-28	Free cash flow margin	Not reported	Revenue: 911000 Open source Operating Cash Flow: -37000 Open source
19981998-02-28	Free cash flow margin	Not reported	Revenue: -270000 Open source Operating Cash Flow: -43000 Open source
19991999-02-28	Free cash flow margin	Not reported	Revenue: -578000 Open source Operating Cash Flow: -236000 Open source
20002000-02-29	Free cash flow margin	Not reported	Revenue: 403000 Open source Operating Cash Flow: -104000 Open source
20012001-02-28	Free cash flow margin	Not reported	Revenue: -383000 Open source Operating Cash Flow: -168000 Open source
20022002-02-28	Free cash flow margin	Not reported	Revenue: 477000 Open source Operating Cash Flow: -178000 Open source
20032003-02-28	Free cash flow margin	Not reported	Revenue: -396000 Open source Operating Cash Flow: -190000 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 1016733 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 3443545 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 30948568 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -190K 2003

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-02-28	Operating cash flow	-37000	Operating Cash Flow: -37000 Open source
19981998-02-28	Operating cash flow	-43000	Operating Cash Flow: -43000 Open source
19991999-02-28	Operating cash flow	-236000	Operating Cash Flow: -236000 Open source
20002000-02-29	Operating cash flow	-104000	Operating Cash Flow: -104000 Open source
20012001-02-28	Operating cash flow	-168000	Operating Cash Flow: -168000 Open source
20022002-02-28	Operating cash flow	-178000	Operating Cash Flow: -178000 Open source
20032003-02-28	Operating cash flow	-190000	Operating Cash Flow: -190000 Open source
20032003-12-31	Operating cash flow	Not reported	No source recorded
20042004-12-31	Operating cash flow	Not reported	No source recorded
20052005-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-02-28	Free cash flow	Unavailable	Operating Cash Flow: -37000 Open source
19981998-02-28	Free cash flow	Unavailable	Operating Cash Flow: -43000 Open source
19991999-02-28	Free cash flow	Unavailable	Operating Cash Flow: -236000 Open source
20002000-02-29	Free cash flow	Unavailable	Operating Cash Flow: -104000 Open source
20012001-02-28	Free cash flow	Unavailable	Operating Cash Flow: -168000 Open source
20022002-02-28	Free cash flow	Unavailable	Operating Cash Flow: -178000 Open source
20032003-02-28	Free cash flow	Unavailable	Operating Cash Flow: -190000 Open source
20032003-12-31	Free cash flow	Unavailable	No source recorded
20042004-12-31	Free cash flow	Unavailable	No source recorded
20052005-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

63.5% 2005

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19971997-02-28	Liabilities / assets	55.5%	Total Liabilities: 1843000 Open source Total Assets: 3318000 Open source
19981998-02-28	Liabilities / assets	65.1%	Total Liabilities: 1777000 Open source Total Assets: 2730000 Open source
19991999-02-28	Liabilities / assets	92.3%	Total Liabilities: 1656000 Open source Total Assets: 1795000 Open source
20002000-02-29	Liabilities / assets	90.4%	Total Liabilities: 1747000 Open source Total Assets: 1932000 Open source
20012001-02-28	Liabilities / assets	136.5%	Total Liabilities: 1937000 Open source Total Assets: 1419000 Open source
20022002-02-28	Liabilities / assets	123.5%	Total Liabilities: 2175000 Open source Total Assets: 1761000 Open source
20032003-02-28	Liabilities / assets	187.2%	Total Liabilities: 2496000 Open source Total Assets: 1333000 Open source
2003-12-31	Liabilities / assets	Not reported	No source recorded
2004-12-31	Liabilities / assets	Not reported	Total Assets: 10523229 Open source
20052005-12-31	Liabilities / assets	63.5%	Total Liabilities: 16893936 Open source Total Assets: 26621074 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.8× 2005

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1997-02-28	Current assets / current liabilities	Not reported	No source recorded
1998-02-28	Current assets / current liabilities	Not reported	No source recorded
1999-02-28	Current assets / current liabilities	Not reported	No source recorded
2000-02-29	Current assets / current liabilities	Not reported	No source recorded
2001-02-28	Current assets / current liabilities	Not reported	No source recorded
2002-02-28	Current assets / current liabilities	Not reported	No source recorded
2003-02-28	Current assets / current liabilities	Not reported	No source recorded
2003-12-31	Current assets / current liabilities	Not reported	No source recorded
20042004-12-31	Current assets / current liabilities	0.97×	Current Assets: 7029366 Open source Current Liabilities: 7276923 Open source
20052005-12-31	Current assets / current liabilities	0.8×	Current Assets: 12744880 Open source Current Liabilities: 15876834 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1997 1996-03-01 – 1997-02-28	USD 647,000 Exact value Exact value: 647000 USD 1996-03-01 – 1997-02-28: 647000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 1997-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Net Income: 647000 USD Concept: fundies:NetIncome Period: 1996-03-01 to 1997-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3ANetIncome&period=1997-02-28&surface=latest&period_type=duration&start=1996-03-01&unit=USD&dimensions= Input fundies:NetIncome: 647000 USD (1996-03-01 to 1997-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0000891554-99-001261.txt#913 The citation records this snapshot. The page link may show a newer release later.	−USD 37,000 Exact value Exact value: -37000 USD 1996-03-01 – 1997-02-28: -37000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 1997-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Operating Cash Flow: -37000 USD Concept: fundies:OperatingCashFlow Period: 1996-03-01 to 1997-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3AOperatingCashFlow&period=1997-02-28&surface=latest&period_type=duration&start=1996-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37000 USD (1996-03-01 to 1997-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0000891554-99-001261.txt#927 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1997-03-01 – 1998-02-28	−USD 518,000 Exact value Exact value: -518000 USD 1997-03-01 – 1998-02-28: -518000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 1998-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Net Income: -518000 USD Concept: fundies:NetIncome Period: 1997-03-01 to 1998-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3ANetIncome&period=1998-02-28&surface=latest&period_type=duration&start=1997-03-01&unit=USD&dimensions= Input fundies:NetIncome: -518000 USD (1997-03-01 to 1998-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0000891554-00-001599.txt#872 The citation records this snapshot. The page link may show a newer release later.	−USD 43,000 Exact value Exact value: -43000 USD 1997-03-01 – 1998-02-28: -43000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 1998-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Operating Cash Flow: -43000 USD Concept: fundies:OperatingCashFlow Period: 1997-03-01 to 1998-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3AOperatingCashFlow&period=1998-02-28&surface=latest&period_type=duration&start=1997-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -43000 USD (1997-03-01 to 1998-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0000891554-00-001599.txt#886 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1999 1998-03-01 – 1999-02-28	−USD 814,000 Exact value Exact value: -814000 USD 1998-03-01 – 1999-02-28: -814000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 1999-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Net Income: -814000 USD Concept: fundies:NetIncome Period: 1998-03-01 to 1999-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3ANetIncome&period=1999-02-28&surface=latest&period_type=duration&start=1998-03-01&unit=USD&dimensions= Input fundies:NetIncome: -814000 USD (1998-03-01 to 1999-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0000891554-01-503095.txt#887 The citation records this snapshot. The page link may show a newer release later.	−USD 236,000 Exact value Exact value: -236000 USD 1998-03-01 – 1999-02-28: -236000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 1999-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Operating Cash Flow: -236000 USD Concept: fundies:OperatingCashFlow Period: 1998-03-01 to 1999-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3AOperatingCashFlow&period=1999-02-28&surface=latest&period_type=duration&start=1998-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -236000 USD (1998-03-01 to 1999-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0000891554-01-503095.txt#900 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2000 1999-03-01 – 2000-02-29	USD 46,000 Exact value Exact value: 46000 USD 1999-03-01 – 2000-02-29: 46000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2000-02-29 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Net Income: 46000 USD Concept: fundies:NetIncome Period: 1999-03-01 to 2000-02-29 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3ANetIncome&period=2000-02-29&surface=latest&period_type=duration&start=1999-03-01&unit=USD&dimensions= Input fundies:NetIncome: 46000 USD (1999-03-01 to 2000-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0000891554-02-003884.txt#1100 The citation records this snapshot. The page link may show a newer release later.	−USD 104,000 Exact value Exact value: -104000 USD 1999-03-01 – 2000-02-29: -104000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2000-02-29 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Operating Cash Flow: -104000 USD Concept: fundies:OperatingCashFlow Period: 1999-03-01 to 2000-02-29 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3AOperatingCashFlow&period=2000-02-29&surface=latest&period_type=duration&start=1999-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -104000 USD (1999-03-01 to 2000-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0000891554-02-003884.txt#1112 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2000-03-01 – 2001-02-28	−USD 703,000 Exact value Exact value: -703000 USD 2000-03-01 – 2001-02-28: -703000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2001-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Net Income: -703000 USD Concept: fundies:NetIncome Period: 2000-03-01 to 2001-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3ANetIncome&period=2001-02-28&surface=latest&period_type=duration&start=2000-03-01&unit=USD&dimensions= Input fundies:NetIncome: -703000 USD (2000-03-01 to 2001-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001169232-03-004204.txt#854 The citation records this snapshot. The page link may show a newer release later.	−USD 168,000 Exact value Exact value: -168000 USD 2000-03-01 – 2001-02-28: -168000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2001-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Operating Cash Flow: -168000 USD Concept: fundies:OperatingCashFlow Period: 2000-03-01 to 2001-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3AOperatingCashFlow&period=2001-02-28&surface=latest&period_type=duration&start=2000-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -168000 USD (2000-03-01 to 2001-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001169232-03-004204.txt#865 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2001-03-01 – 2002-02-28	USD 104,000 Exact value Exact value: 104000 USD 2001-03-01 – 2002-02-28: 104000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2002-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Net Income: 104000 USD Concept: fundies:NetIncome Period: 2001-03-01 to 2002-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3ANetIncome&period=2002-02-28&surface=latest&period_type=duration&start=2001-03-01&unit=USD&dimensions= Input fundies:NetIncome: 104000 USD (2001-03-01 to 2002-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001169232-03-004204.txt#854 The citation records this snapshot. The page link may show a newer release later.	−USD 178,000 Exact value Exact value: -178000 USD 2001-03-01 – 2002-02-28: -178000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2002-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Operating Cash Flow: -178000 USD Concept: fundies:OperatingCashFlow Period: 2001-03-01 to 2002-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3AOperatingCashFlow&period=2002-02-28&surface=latest&period_type=duration&start=2001-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -178000 USD (2001-03-01 to 2002-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001169232-03-004204.txt#865 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2002-03-01 – 2003-02-28	−USD 749,000 Exact value Exact value: -749000 USD 2002-03-01 – 2003-02-28: -749000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2003-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Net Income: -749000 USD Concept: fundies:NetIncome Period: 2002-03-01 to 2003-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3ANetIncome&period=2003-02-28&surface=latest&period_type=duration&start=2002-03-01&unit=USD&dimensions= Input fundies:NetIncome: -749000 USD (2002-03-01 to 2003-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001169232-03-004204.txt#854 The citation records this snapshot. The page link may show a newer release later.	−USD 190,000 Exact value Exact value: -190000 USD 2002-03-01 – 2003-02-28: -190000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2003-02-28 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Operating Cash Flow: -190000 USD Concept: fundies:OperatingCashFlow Period: 2002-03-01 to 2003-02-28 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3AOperatingCashFlow&period=2003-02-28&surface=latest&period_type=duration&start=2002-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -190000 USD (2002-03-01 to 2003-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001169232-03-004204.txt#865 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	USD 484,175 Exact value Exact value: 484175 USD 2003-01-01 – 2003-12-31: 484175 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2003-12-31 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Net Income: 484175 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 484175 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001010549-05-000258.txt#2433 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	USD 350,640 Exact value Exact value: 350640 USD 2004-01-01 – 2004-12-31: 350640 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2004-12-31 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Net Income: 350640 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: 350640 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001144204-06-035948.txt#10945 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	USD 960,685 Exact value Exact value: 960685 USD 2005-01-01 – 2005-12-31: 960685 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMACEUTICALS HOLDINGS INC · 2005-12-31 CHINA BIOPHARMACEUTICALS HOLDINGS INC (edgar:352868) Net Income: 960685 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:48:09Z Snapshot: 44a03e2970976eca7cc40173eb299f278c73398a4036c913bf0c0af1e5379060 Dimensions: Consolidated View: https://fundies.io/companies/edgar/352868/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 960685 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/352868/0001144204-06-035948.txt#10945 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

64 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000352868, 352868, edgar:352868

Also known as GLOBUS GROWTH GROUP INC

CHINA BIOPHARMACEUTICALS HOLDINGS INC

Latest quarter

Revenue

Operating margin

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2005 2005-01-01 – 2005-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation